B. Zimmermanns

Translational Development of a Zr-89-Labeled Inhibitor of Prostate-specific Membrane Antigen for PET Imaging in Prostate Cancer

A. Drzezga, H. Endepols, F. Dietlein, 2021, Molecular Imaging and Biology.

Stability of radioactive colloids for radiation synovectomy: influence of X-ray contrast agents, anaesthetics and glucocorticoids in vitro

M. Dietlein, H. Schicha, T. Fischer, 2005, Nuclear medicine communications.

Radioimmunotherapy with yttrium-90 ibritumomab tiuxetan Clinical considerations, radiopharmacy, radiation protection, perspectives

M. Dietlein, W. Eschner, R. Schnell, 2005 .

Development of anti-CD30 radioimmunoconstructs (RICs) for treatment of Hodgkin's lymphoma

M. Dietlein, H. Schicha, C. Kobe, 2010, Nuklearmedizin.

Exhalation of 131I after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air.

A. Drzezga, F. Sudbrock, T. Fischer, 2017, Journal of environmental radioactivity.

Influence of iodine supply on the radiation-induced DNA-fragmentation.

A. Drzezga, F. Sudbrock, W. Baus, 2017, Journal of environmental radioactivity.

Retention efficacy and release of radioiodine in fume hoods.

A. Drzezga, O. Prante, F. Sudbrock, 2017, Journal of Environmental Radioactivity.

Characterization of SnO2-based 68Ge/68Ga generators and 68Ga-DOTATATE preparations: radionuclide purity, radiochemical yield and long-term constancy

A. Drzezga, M. Dietlein, F. Sudbrock, 2014, EJNMMI Research.